Previous Chapter: References
Suggested Citation: "Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23530.

Appendix A

Workshop Agenda

APRIL 9, 2015

Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials

8:30–8:45 a.m.

Welcome and Overview

Victor Dzau, M.D.

President, National Academy of Medicine

Antonia M. Villarruel, Ph.D.

Roundtable Chair

Dean, College of Nursing, University of Pennsylvania

Jonca Bull, M.D.

Director, Office of Minority Health, U.S. Food and Drug Administration (FDA)

8:45–10:15 a.m.

Panel 1: Historical Perspectives and Context

Moderator: Chazeman Jackson, Ph.D., Office of Minority Health, U.S. Department of Health and Human Services

Amelie Ramirez, Dr.P.H.

University of Texas Health Sciences Center

Suggested Citation: "Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23530.

Otis Brawley, M.D., F.A.C.P.

American Cancer Society

Charles Rotimi, Ph.D.

National Institutes of Health (NIH)

10:15–10:30 a.m. BREAK
10:30 a.m.–12:00 p.m.

Panel 2: Scientific Issues: Clinically Meaningful Inclusion

Moderator: Allan Goldberg, M.D., Merck & Co., Inc.

Objectives:

  • Study design adequacy for subpopulation analyses and outcomes
  • Inclusion/exclusion criteria that results in unintentional bias against some populations
  • Research designs that are relevant to diverse populations and subpopulation analyses

    Dave Hickam, M.D., M.P.H.

    Patient-Centered Outcomes Research Institute

    Jocelyn Ulrich, M.P.H., R.A.C.

    Pharmaceutical Research and Manufacturers of America

    Carol Horowitz, M.D., M.P.H.

    Mount Sinai

12:00–1:00 p.m. LUNCH
1:00–2:30 p.m.

Panel 3: Recruitment and Retention Issues: Patient, Provider, Institutional, and System Barriers

Moderator: Deidra Crews, M.D., S.C.M., Gilbert S. Omenn Anniversary Fellow of the Institute of Medicine, Johns Hopkins University

Objectives:

  • Describe barriers to research, including culturally incongruent research designs, inaccessibility of clinical trials locations to diverse communities, inadequate outreach, and legal status
  • Community engagement in clinical trials research
Suggested Citation: "Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23530.

Connie Ulrich, Ph.D., R.N., F.A.A.N.

University of Pennsylvania

Jonathan Ellen, M.D.

Johns Hopkins All Children’s Hospital

Moon Chen, Ph.D., M.P.H.

University of California, Davis

2:30–2:45 p.m. BREAK
2:45–4:15 p.m.

Panel 4: Best Practices and Policy Recommendations

Moderator: Francisco García, Pima County Health Department

Karen Kim, M.D.

University of Chicago

Teshia Solomon, Ph.D.

University of Arizona

Sandra E. Brooks, M.D., M.B.A.

University of Louisville

4:15–4:45 p.m.

Concluding Reflections

Toni Villarruel, Ph.D., R.N., F.A.A.N.

Roundtable Chair

Barbara Buch, M.D.

FDA

4:45 p.m. ADJOURN
Suggested Citation: "Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23530.

This page intentionally left blank.

Suggested Citation: "Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23530.
Page 55
Suggested Citation: "Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23530.
Page 56
Suggested Citation: "Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23530.
Page 57
Suggested Citation: "Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23530.
Page 58
Next Chapter: Appendix B: Speaker Biographical Sketches
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.